Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway

References

• Costa PM, Cardoso A, Mano M, et al. MicroRNAs in glioblastoma: role in pathogenesis and opportunities for targeted therapies. CNS Neurol Disord Drug Targets. 2015;14(2):222–238.
   PubMed Web of Science ®Google Scholar
• Van Meir EG, Costas G. Hadjipanayis, Andrew D. Norden, Hui-Kuo Shu, Patrick Y. Wen,Jeffrey J. Olson, et al. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010;60(3):166–193.
   PubMed Web of Science ®Google Scholar
• Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013;20(3):300–307.
   PubMed Web of Science ®Google Scholar
• Thrash-Bingham CA, Tartof KD. aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J Natl Cancer Inst. 1999;91(2):143–151.
   PubMedGoogle Scholar
• Kotake Y, T Nakagawa, K Kitagawa, S Suzuki, N Liu, M Kitagawa & Y Xiong. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2011;30(16):1956–1962.
   PubMed Web of Science ®Google Scholar
• Kino T, Darrell E. Hurt, Takamasa Ichijo, Nancy Nader, and George P. Chrousos. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal. 2010;3(107):a8.
   Web of Science ®Google Scholar
• Ji P, Diederichs S, Wang W, et al. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031–8041.
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang Y, Luan W, et al. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS One. 2014;9(1):e86295.
   PubMed Web of Science ®Google Scholar
• Qi Y, Zhixing Wang, Fan Wu, Bin Yin,Tao Jiang, Boqin Qiang, Jiangang Yuan, Wei Han, Xiaozhong Peng. Long noncoding RNA HOXD-AS2 regulates cell cycle to promote glioma progression. J Cell Biochem. 2018. https://doi.org/10.1002/jcb.28117
   Web of Science ®Google Scholar
• Nie E, Jin X, Miao F, et al. TGF-β1 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT. Neuro Oncol. 2021;23(3):435–446.
   PubMed Web of Science ®Google Scholar
• Rosebeck S, Rehman AO, Lucas PC, et al. From MALT lymphoma to the CBM signalosome: three decades of discovery. Cell Cycle. 2011;10(15):2485–2496.
   PubMed Web of Science ®Google Scholar
• Afonina IS, Elton L, Carpentier I, et al. MALT1 - a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression. FEBS J. 2015;282(17):3286–3297.
   PubMed Web of Science ®Google Scholar
• Young RM, Staudt LM. A new “brew” of MALT1 inhibitors. Cancer Cell. 201 2;22(6):706–707.
   PubMed Web of Science ®Google Scholar
• Uren AG, et al. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell. 2000;6(4):961–967.
   PubMed Web of Science ®Google Scholar
• Yang F, Liu X, Liu Y, et al. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma. Cancer Lett. 2017;396:1–9.
   PubMed Web of Science ®Google Scholar
• Shi F, Zhang Y, Wang J, et al. Retracted Article: RNA-sequencing identified miR-3681 as a negative regulator in the proliferation and migration of cervical cancer cells via the posttranscriptional suppression of HGFR. RSC Adv. 2019;9(39):22376–22383.
   PubMed Web of Science ®Google Scholar
• Fan Y-C, Mei P-J, Chen C, et al. MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis. J Neurooncol. 2013;115(2):179–188.
   PubMed Web of Science ®Google Scholar
• Yang X, W. Zhang, S.-Q. Cheng, R.-L. Yang. High expression of lncRNA GACAT3 inhibits invasion and metastasis of non-small cell lung cancer to enhance the effect of radiotherapy. Eur Rev Med Pharmacol Sci. 2018;22(5):1315–1322.
   PubMed Web of Science ®Google Scholar
• Liu X, Yue C, Shi L, et al. MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation. J Cell Mol Med. 2020;24(13):7550–7562.
   PubMed Web of Science ®Google Scholar
• Harford-Wright E, Andre-Gregoire G, Jacobs KA, et al. Pharmacological targeting of apelin impairs glioblastoma growth. Brain. 2017;140(11):2939–2954.
   PubMedGoogle Scholar
• Arancio W, Pizzolanti G, Genovese SI, et al. Competing endogenous RNA and interactome bioinformatic analyses on human telomerase. Rejuvenation Res. 2014;17(2):161–167.
   PubMed Web of Science ®Google Scholar
• Sen R, Ghosal S, Das S, et al. Competing endogenous RNA: the key to posttranscriptional regulation. ScientificWorldJournal. 2014;2014:896206.
   PubMedGoogle Scholar
• Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016;1402:271–286.
   PubMedGoogle Scholar
• Liao Y, Shen L, Zhao H, et al. LncRNA CASC2 interacts with miR-181a to modulate glioma growth and resistance to TMZ through PTEN pathway. J Cell Biochem. 2017;118(7):1889–1899.
   PubMed Web of Science ®Google Scholar
• Zhang T, Y.-R. Wang, F. Zeng, H.-Y. Cao, H.-D. Zhou, Y.-J. Wang. LncRNA H19 is overexpressed in glioma tissue, is negatively associated with patient survival, and promotes tumor growth through its derivative miR-675. Eur Rev Med Pharmacol Sci. 2016;20(23):4891–4897.
   PubMed Web of Science ®Google Scholar
• Zhao H, Peng R, Liu Q, et al. The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP. Arch Biochem Biophys. 2016;610:1–7.
   PubMed Web of Science ®Google Scholar
• Zhu X, Li W, Li Y, et al. The antidepressant- and anxiolytic-like effects of resveratrol: involvement of phosphodiesterase-4D inhibition. Neuropharmacology. 2019;153:20–31.
   PubMed Web of Science ®Google Scholar
• Yeh C-N, Chang Y-C, Su Y, et al. Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients. Oncotarget. 2017;8(69):113444–113459.
   PubMedGoogle Scholar
• Pan D, Jiang C, Ma Z, et al. MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression. Oncogene. 2016;35(7):919–928.
   PubMed Web of Science ®Google Scholar
• Qin S, Dexu Sun, Jingjing Mu, Daifu Ma, Renxian Tang, Yuanlin Zheng. Purple sweet potato color improves hippocampal insulin resistance via down-regulating SOCS3 and galectin-3 in high-fat diet mice. Behav Brain Res. 2019;359:370–377.
   PubMed Web of Science ®Google Scholar